Novartis Ag (NVS) Exchange Rate Effect (2009 - 2026)

Novartis Ag (NVS) has 16 years of Exchange Rate Effect data on file, last reported at -$77.0 million in Q1 2026.

• Quarterly Exchange Rate Effect fell 142.78% year-over-year to -$77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $319.0 million (up 3887.5% YoY) and the FY2025 annual result came in at $576.0 million, up 293.29% from the prior year.
• Exchange Rate Effect declined to -$77.0 million in Q1 2026 per NVS's latest filing, from $36.0 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $382.0 million in Q2 2025, with the low at -$314.0 million in Q4 2024.
• Average Exchange Rate Effect over 5 years is $15.8 million, with a median of -$22.0 million recorded in 2025.
• Year-over-year, Exchange Rate Effect slumped 3300.0% in 2024 and jumped 1223.53% in 2025.
• Novartis Ag's Exchange Rate Effect stood at $141.0 million in 2022, then gained by 13.48% to $160.0 million in 2023, then tumbled by 296.25% to -$314.0 million in 2024, then surged by 111.46% to $36.0 million in 2025, then sank by 313.89% to -$77.0 million in 2026.
• Business Quant data shows NVS's Exchange Rate Effect at -$77.0 million in Q1 2026, $36.0 million in Q4 2025, and -$22.0 million in Q3 2025.